Narges Mohammadi, the imprisoned Iranian Nobel Peace Prize laureate, was rushed from Zanjan prison to a local hospital on Friday after suffering two episodes of complete unconsciousness and an acute heart attack, according to her foundation. The transfer came after what her supporters describe as 140 days of systematic medical neglect, during which her health underwent a catastrophic decline. Doctors at the facility have since placed her in the cardiac intensive care unit, where she remains on supplementary oxygen, with unstable blood pressure and persistent nausea, her brother Hamid Reza Mohammadi confirmed from his home in Norway. He added that six independent physicians had previously recommended she spend at least a month away from prison conditions, a recommendation even acknowledged by judicial authorities, yet no action was taken until the emergency arose.

From Oslo, the chair of the Norwegian Nobel Committee, Jørgen Watne Frydenlund, issued an unusually direct statement warning that Mohammadi’s life now rests entirely in the hands of Iranian authorities. He urged the immediate transfer of the activist from the Zanjan hospital to her own medical team in Tehran, arguing that continued refusal to allow this would constitute a direct threat to her survival. The committee, Frydenlund stressed, is maintaining constant contact with her family and legal representatives. A coalition of Nobel laureates under the Women Nobel Initiative also released a statement on May 2, expressing deep alarm and demanding urgent specialist care, describing her condition as life-threatening.

Viewed from Tehran, the situation presents a delicate test for the Islamic Republic. While authorities have belatedly permitted hospitalisation, they have so far resisted moving Mohammadi to the capital, where she could access an angiogram and the specialist cardiology team she trusts. The Foundation for Narges Mohammadi argues that without such a transfer, accurate diagnosis and appropriate treatment remain impossible. Analysts in London note that the regime’s handling of this case carries significant reputational risk, particularly as the international community watches closely during a period of heightened diplomatic tension over Iran’s nuclear programme and human rights record. The question now is whether pragmatism—or intransigence—will prevail. With each passing day that Mohammadi remains in a provincial ICU rather than Tehran, the gap between official rhetoric and medical reality widens, and the cost to Iran’s standing abroad deepens.